The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Zuberbier, Torsten
- dc.contributor.author Giménez Arnau, Anna Maria
- dc.contributor.author Maurer, Marcus
- dc.date.accessioned 2022-05-05T07:41:02Z
- dc.date.available 2022-05-05T07:41:02Z
- dc.date.issued 2022
- dc.description.abstract This update and revision of the international guideline for urticaria was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. It is a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the Global Allergy and Asthma European Network (GA²LEN) and its Urticaria and Angioedema Centers of Reference and Excellence (UCAREs and ACAREs), the European Dermatology Forum (EDF; EuroGuiDerm), and the Asia Pacific Association of Allergy, Asthma and Clinical Immunology with the participation of 64 delegates of 50 national and international societies and from 31 countries. The consensus conference was held on 3 December 2020. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS). Urticaria is a frequent, mast cell-driven disease that presents with wheals, angioedema, or both. The lifetime prevalence for acute urticaria is approximately 20%. Chronic spontaneous or inducible urticaria is disabling, impairs quality of life, and affects performance at work and school. This updated version of the international guideline for urticaria covers the definition and classification of urticaria and outlines expert-guided and evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria.
- dc.format.mimetype application/pdf
- dc.identifier.citation Zuberbier T, Abdul Latiff AH, Abuzakouk M, Aquilina S, Asero R, Baker D, et al. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticària. Allergy. 2022 Mar; 77(3): 734-66. DOI: 10.1111/all.15090
- dc.identifier.doi http://dx.doi.org/10.1111/all.15090
- dc.identifier.issn 0105-4538
- dc.identifier.uri http://hdl.handle.net/10230/52991
- dc.language.iso eng
- dc.publisher Wiley
- dc.rights This is the peer reviewed version of the following article: [Zuberbier T, Abdul Latiff AH, Abuzakouk M, Aquilina S, Asero R, Baker D, et al. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticària. Allergy. 2022 Mar; 77(3): 734-66, which has been published in final form at http://dx.doi.org/10.1111/all.15090. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.subject.keyword Angioedema
- dc.subject.keyword Consensus
- dc.subject.keyword Evidence-based
- dc.subject.keyword Hives
- dc.subject.keyword Itch
- dc.subject.keyword Mast cell
- dc.subject.keyword Urticaria
- dc.title The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/acceptedVersion